$EMLR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Talon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Talon Therapeutics, Inc.. Get notifications about new insider transactions in Talon Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 09 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.22 | 57,165 | 69,741 | 34,252 | 91.4 K to 34.3 K (-62.53 %) |
Aug 17 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | C | 100.00 | 54,000 | 5,400,000 | 510,000 | |
Aug 17 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | C | 0.35 | 54,000 | 18,900 | 81,000 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.35 | 1,543 | 540 | 1,543 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.35 | 958 | 335 | 958 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.35 | 323 | 113 | 323 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.35 | 176 | 62 | 176 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 3,472 | 1,042 | 1 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 2,155 | 647 | 1 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 728 | 218 | 1 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 397 | 119 | 1 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 3,472 | 1,042 | 16,110 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 2,155 | 647 | 10,000 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 728 | 218 | 3,378 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 397 | 119 | 1,842 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.33 | 283,180 | 376,629 | 299,811 | 583 K to 299.8 K (-48.57 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.33 | 175,782 | 233,790 | 186,037 | 361.8 K to 186 K (-48.58 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.33 | 59,388 | 78,986 | 252,561 | 311.9 K to 252.6 K (-19.04 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.33 | 32,402 | 43,095 | 125,150 | 157.6 K to 125.2 K (-20.57 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 85,623 | 102,748 | 582,991 | 668.6 K to 583 K (-12.81 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 53,150 | 63,780 | 361,819 | 415 K to 361.8 K (-12.81 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 17,957 | 21,548 | 311,949 | 329.9 K to 311.9 K (-5.44 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 9,797 | 11,756 | 157,552 | 167.3 K to 157.6 K (-5.85 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.14 | 82,321 | 93,846 | 668,614 | 750.9 K to 668.6 K (-10.96 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.14 | 51,091 | 58,244 | 414,969 | 466.1 K to 415 K (-10.96 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.14 | 40,619 | 46,306 | 329,906 | 370.5 K to 329.9 K (-10.96 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.14 | 20,604 | 23,489 | 167,349 | 188 K to 167.3 K (-10.96 %) |
Jul 03 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | C | 100.00 | 27,000 | 2,700,000 | 570,000 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | C | 0.35 | 27,000 | 9,450 | 27,000 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | C | 100.00 | 27,000 | 2,700,000 | 570,000 | |
Jul 03 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | C | 0.35 | 27,000 | 9,450 | 27,000 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 3,472 | 1,042 | 1 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 2,155 | 647 | 1 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 728 | 218 | 1 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 397 | 119 | 1 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 3,472 | 1,042 | 12,638 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 2,155 | 647 | 7,845 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 728 | 218 | 2,650 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | C | 0.30 | 397 | 119 | 1,445 | |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 27,500 | 26,950 | 919,426 | 946.9 K to 919.4 K (-2.90 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 70,184 | 69,482 | 946,926 | 1 M to 946.9 K (-6.90 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 17,123 | 16,781 | 570,632 | 587.8 K to 570.6 K (-2.91 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 43,600 | 43,164 | 587,755 | 631.4 K to 587.8 K (-6.91 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 11,900 | 11,662 | 453,663 | 465.6 K to 453.7 K (-2.56 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 30,400 | 30,096 | 465,563 | 496 K to 465.6 K (-6.13 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 8,577 | 8,405 | 230,125 | 238.7 K to 230.1 K (-3.59 %) |
May 07 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 21,816 | 21,598 | 238,702 | 260.5 K to 238.7 K (-8.37 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 92,964 | 99,471 | 750,935 | 843.9 K to 750.9 K (-11.02 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 57,697 | 61,736 | 466,060 | 523.8 K to 466.1 K (-11.02 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 45,871 | 49,082 | 370,525 | 416.4 K to 370.5 K (-11.02 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 23,268 | 24,897 | 187,953 | 211.2 K to 188 K (-11.02 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 49,170 | 49,170 | 843,899 | 893.1 K to 843.9 K (-5.51 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 30,517 | 30,517 | 523,757 | 554.3 K to 523.8 K (-5.51 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 24,262 | 24,262 | 416,396 | 440.7 K to 416.4 K (-5.51 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 12,307 | 12,307 | 211,221 | 223.5 K to 211.2 K (-5.51 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 26,357 | 25,830 | 893,069 | 919.4 K to 893.1 K (-2.87 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 16,358 | 16,031 | 554,274 | 570.6 K to 554.3 K (-2.87 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 13,005 | 12,745 | 440,658 | 453.7 K to 440.7 K (-2.87 %) |
Jun 28 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 6,597 | 6,465 | 223,528 | 230.1 K to 223.5 K (-2.87 %) |
May 23 2012 | EMLR | Talon Therapeutics ... | DeZao Thomas | VP, Comm. Oper. & P ... | Option Exercise | A | 0.75 | 200,000 | 149,000 | 200,000 | |
Apr 24 2012 | EMLR | Talon Therapeutics ... | PIEN HOWARD H | Director | Option Exercise | A | 0.82 | 50,000 | 41,000 | 50,000 | |
Mar 23 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 48,600 | 51,030 | 1,017,110 | 1.1 M to 1 M (-4.56 %) |
Mar 23 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 30,226 | 31,737 | 631,355 | 661.6 K to 631.4 K (-4.57 %) |
Mar 23 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 21,074 | 22,128 | 495,963 | 517 K to 496 K (-4.08 %) |
Mar 23 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 15,100 | 15,855 | 260,518 | 275.6 K to 260.5 K (-5.48 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 15,025 | 15,175 | 1,065,710 | 1.1 M to 1.1 M (-1.39 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 9,326 | 9,419 | 661,581 | 670.9 K to 661.6 K (-1.39 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 7,290 | 7,363 | 517,037 | 524.3 K to 517 K (-1.39 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 3,885 | 3,924 | 275,618 | 279.5 K to 275.6 K (-1.39 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 7,824 | 8,137 | 1,080,735 | 1.1 M to 1.1 M (-0.72 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 4,857 | 5,051 | 670,907 | 675.8 K to 670.9 K (-0.72 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 3,796 | 3,948 | 524,327 | 528.1 K to 524.3 K (-0.72 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 2,023 | 2,104 | 279,503 | 281.5 K to 279.5 K (-0.72 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 52,094 | 57,824 | 1,088,559 | 1.1 M to 1.1 M (-4.57 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 32,339 | 35,896 | 675,764 | 708.1 K to 675.8 K (-4.57 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 25,275 | 28,055 | 528,123 | 553.4 K to 528.1 K (-4.57 %) |
Mar 14 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 13,472 | 14,954 | 281,526 | 295 K to 281.5 K (-4.57 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 64,706 | 77,647 | 1,140,653 | 1.2 M to 1.1 M (-5.37 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 40,167 | 48,200 | 708,103 | 748.3 K to 708.1 K (-5.37 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 31,393 | 37,672 | 553,398 | 584.8 K to 553.4 K (-5.37 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.20 | 16,734 | 20,081 | 294,998 | 311.7 K to 295 K (-5.37 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 23,261 | 24,191 | 1,205,359 | 1.2 M to 1.2 M (-1.89 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 14,439 | 15,017 | 748,270 | 762.7 K to 748.3 K (-1.89 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 11,285 | 11,736 | 584,791 | 596.1 K to 584.8 K (-1.89 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.04 | 6,015 | 6,256 | 311,732 | 317.7 K to 311.7 K (-1.89 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 8,881 | 8,792 | 1,228,620 | 1.2 M to 1.2 M (-0.72 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 5,513 | 5,458 | 762,709 | 768.2 K to 762.7 K (-0.72 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 4,310 | 4,267 | 596,076 | 600.4 K to 596.1 K (-0.72 %) |
Mar 12 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 2,296 | 2,273 | 317,747 | 320 K to 317.7 K (-0.72 %) |
Feb 22 2012 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 0.91 | 65,000 | 58,825 | 65,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.91 | 47,000 | 42,535 | 47,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | Spiegel Robert J. | Director | Option Exercise | A | 0.91 | 35,000 | 31,675 | 35,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 0.91 | 35,000 | 31,675 | 35,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | Furst Howard P. | Director | Option Exercise | A | 0.91 | 35,000 | 31,675 | 35,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | Ferrer Andrew | Director | Option Exercise | A | 0.91 | 35,000 | 31,675 | 35,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | CARLSON CRAIG W | Chief Financial Off ... | Option Exercise | A | 0.91 | 400,000 | 362,000 | 400,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | A | 0.91 | 35,000 | 31,675 | 35,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | A | 0.91 | 50,000 | 45,250 | 50,000 | |
Feb 22 2012 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.91 | 1,000,000 | 905,000 | 1,000,000 | |
Feb 08 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 10,600 | 10,388 | 1,237,501 | 1.2 M to 1.2 M (-0.85 %) |
Feb 08 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 6,536 | 6,405 | 768,222 | 774.8 K to 768.2 K (-0.84 %) |
Feb 08 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 4,564 | 4,473 | 600,386 | 605 K to 600.4 K (-0.75 %) |
Feb 08 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 3,300 | 3,234 | 320,043 | 323.3 K to 320 K (-1.02 %) |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.30 | 9,166 | 2,750 | 9,166 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.30 | 5,690 | 1,707 | 5,690 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.30 | 1,922 | 577 | 1,922 | |
Jan 11 2012 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.30 | 1,048 | 314 | 1,048 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | A | 100.00 | 1 | 100 | 1 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | GONZALO CECILIA | Director | Option Exercise | A | 0.30 | 99,000 | 29,700 | 99,000 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 100.00 | 1 | 100 | 1 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 0.30 | 99,000 | 29,700 | 99,000 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | A | 100.00 | 1 | 100 | 1 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO. | Director | Option Exercise | A | 0.30 | 99,000 | 29,700 | 99,000 | |
Jan 10 2012 | EMLR | Talon Therapeutics ... | Gharib Samir M. | Controller, Direct. ... | Option Exercise | A | 0.49 | 75,000 | 36,375 | 75,000 | |
Sep 28 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 3,161 | 3,161 | 1,248,101 | 1.3 M to 1.2 M (-0.25 %) |
Sep 28 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 1,962 | 1,962 | 774,758 | 776.7 K to 774.8 K (-0.25 %) |
Sep 28 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 1,528 | 1,528 | 604,950 | 606.5 K to 605 K (-0.25 %) |
Sep 28 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 849 | 849 | 323,343 | 324.2 K to 323.3 K (-0.26 %) |
Sep 26 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 4,843 | 4,746 | 1,251,262 | 1.3 M to 1.3 M (-0.39 %) |
Sep 26 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 3,007 | 2,947 | 776,720 | 779.7 K to 776.7 K (-0.39 %) |
Sep 26 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 2,342 | 2,295 | 606,478 | 608.8 K to 606.5 K (-0.38 %) |
Sep 26 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.98 | 1,301 | 1,275 | 324,192 | 325.5 K to 324.2 K (-0.40 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 10,746 | 10,746 | 1,256,106 | 1.3 M to 1.3 M (-0.85 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 6,671 | 6,671 | 779,727 | 786.4 K to 779.7 K (-0.85 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 5,196 | 5,196 | 608,820 | 614 K to 608.8 K (-0.85 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 2,886 | 2,886 | 325,493 | 328.4 K to 325.5 K (-0.88 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 13,907 | 14,602 | 1,266,852 | 1.3 M to 1.3 M (-1.09 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 8,633 | 9,065 | 786,398 | 795 K to 786.4 K (-1.09 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 6,725 | 7,061 | 614,016 | 620.7 K to 614 K (-1.08 %) |
Sep 21 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.05 | 3,735 | 3,922 | 328,379 | 332.1 K to 328.4 K (-1.12 %) |
Sep 02 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.97 | 36,032 | 34,951 | 1,280,759 | 1.3 M to 1.3 M (-2.74 %) |
Sep 02 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.97 | 22,367 | 21,696 | 795,031 | 817.4 K to 795 K (-2.74 %) |
Sep 02 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.97 | 17,423 | 16,900 | 620,741 | 638.2 K to 620.7 K (-2.73 %) |
Sep 02 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.97 | 9,678 | 9,388 | 332,114 | 341.8 K to 332.1 K (-2.83 %) |
Jul 18 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 5,563 | 5,507 | 1,316,791 | 1.3 M to 1.3 M (-0.42 %) |
Jul 18 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 3,453 | 3,418 | 817,398 | 820.9 K to 817.4 K (-0.42 %) |
Jul 18 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 2,690 | 2,663 | 638,164 | 640.9 K to 638.2 K (-0.42 %) |
Jul 18 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 1,494 | 1,479 | 341,792 | 343.3 K to 341.8 K (-0.44 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.06 | 6,531 | 6,923 | 1,322,354 | 1.3 M to 1.3 M (-0.49 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.06 | 4,055 | 4,298 | 820,851 | 824.9 K to 820.9 K (-0.49 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.06 | 3,159 | 3,349 | 640,854 | 644 K to 640.9 K (-0.49 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.06 | 1,755 | 1,860 | 343,286 | 345 K to 343.3 K (-0.51 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 54,785 | 58,620 | 1,328,885 | 1.4 M to 1.3 M (-3.96 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 34,008 | 36,389 | 824,906 | 858.9 K to 824.9 K (-3.96 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 26,491 | 28,345 | 644,013 | 670.5 K to 644 K (-3.95 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 14,716 | 15,746 | 345,041 | 359.8 K to 345 K (-4.09 %) |